Announced Thu, 9 Jul · 16:34 IST
Hester Biosciences fully exits Texas Lifesciences with sale of remaining 11% stake
Strategic Transactions View source PDF
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+21.6%1-day move
₹2092.70
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+21.6+12.9+14.8+16.6+18.9+16.7————
Up moveDown movePending
AI summary
Hester Biosciences has transferred its remaining 543,248 equity shares (11% of paid-up capital) in Texas Lifesciences Private Limited to existing shareholders for an aggregate consideration of INR 23 million. Post this sale, the company's shareholding in TLPL stands reduced from 11% to nil, marking a complete exit from this investment.
Likely market impact
Minor divestment of a small non-core minority stake; cash inflow of about INR 23 million with negligible impact on financials.